Published in Diabet Med on December 01, 2012
Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology (2000) 3.94
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes (2009) 2.80
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet (1996) 2.48
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes (1996) 2.33
Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med (2011) 2.30
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care (2005) 2.26
Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care (2011) 2.20
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care (2011) 2.16
Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes. Diabetologia (2011) 2.07
Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study. Diabetologia (2015) 2.05
The bacteriology of gangrenous and perforated appendicitis--revisited. Ann Surg (1990) 2.05
A microbiological comparison between acute and complicated appendicitis. Clin Infect Dis (1992) 2.02
Bilophila wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces. J Gen Microbiol (1989) 1.98
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia (2011) 1.90
Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia (2003) 1.84
Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol (2011) 1.82
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes. Diabet Med (2008) 1.52
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia (2011) 1.51
Peripheral retinal angiomalike lesion and macular pucker. Am J Ophthalmol (1989) 1.47
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure? Diabetologia (2003) 1.41
Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation (1997) 1.41
Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci (2001) 1.41
Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes. Diabetes (2015) 1.40
Phenotypic identification of Actinomyces and related species isolated from human sources. J Clin Microbiol (2001) 1.39
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial. Diabetes Obes Metab (2011) 1.32
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest (1997) 1.30
Clostridium clostridioforme: a mixture of three clinically important species. Eur J Clin Microbiol Infect Dis (2005) 1.29
Oral colonization with Actinomyces species in infants by two years of age. J Dent Res (2000) 1.29
One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment. Diabetes Obes Metab (2012) 1.26
Barriers to self-management of diabetes. Diabet Med (2013) 1.26
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia (1998) 1.25
Heritability of proliferative diabetic retinopathy. Diabetes (2008) 1.25
Bilophila wadsworthia isolates from clinical specimens. J Clin Microbiol (1992) 1.21
Cellular fatty acid composition, soluble-protein profile, and antimicrobial resistance pattern of Eubacterium lentum. J Clin Microbiol (1998) 1.21
Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes (2008) 1.20
Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics (2011) 1.19
Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care (2009) 1.18
Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst (1999) 1.17
Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia (2007) 1.14
A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes (2001) 1.13
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia (2009) 1.11
Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant (2009) 1.10
Screening for metastatic malignant melanoma of the uvea revisited. Cancer (1999) 1.10
Role of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in extraoral and some odontogenic infections. Clin Infect Dis (1997) 1.09
Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia (2010) 1.08
Relationship between lipid profiles and kidney function in patients with type 1 diabetes. Diabetologia (2007) 1.07
Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy. Ophthalmology (1998) 1.07
Clostridium bartlettii sp. nov., isolated from human faeces. Anaerobe (2004) 1.05
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia (2004) 1.05
Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. MAGMA (2006) 1.04
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care (2008) 1.04
Glucose variability, blood pressure and arterial stiffness in type 1 diabetes. Diabetes Res Clin Pract (2008) 1.03
Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci (1999) 1.02
Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia (2000) 1.01
Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens (2012) 1.01
Activity of metronidazole and its hydroxy metabolite against clinical isolates of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol (1988) 1.00
Physical activity and diabetes complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study. Diabetes Care (2007) 0.98
Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia (2009) 0.98
Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care (2013) 0.98
Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur J Clin Nutr (2010) 0.98
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care (1999) 0.97
Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia (1998) 0.97
Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism. Diabetes (1999) 0.96
Selective medium for isolation of Bacteroides gracilis. J Clin Microbiol (1990) 0.95
Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes. J Clin Endocrinol Metab (2001) 0.94
Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis. Neurology (2011) 0.94
Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care (2010) 0.94
Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease. Acta Neurochir (Wien) (1999) 0.92
Clinical importance of Bilophila wadsworthia. Eur J Clin Microbiol Infect Dis (1992) 0.92
Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy? Diabetologia (2012) 0.92
Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia (2008) 0.92
Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia (2007) 0.91
Early autonomic dysfunction in type 1 diabetes: a reversible disorder? Diabetologia (2009) 0.91